
Tips for getting through treatment with a radiation therapy mask
Nick brings over a decade of experience in healthcare leadership, with a strong focus on operational excellence and building collaborative relationships with doctors and clinical teams. His expertise and passion for patient-centred care make him ideally positioned to lead this first-of-its-kind centre.
The Hollywood facility, which is delivered in partnership with Perth Molecular Imaging and Theranostics Centre (PMITC), will deliver an integrated private service combining advanced PET-CT and SPECT-CT imaging, targeted radiopharmaceutical therapies, and access to global clinical trials, bringing the latest in precision medicine to patients across the state and beyond.
Nick will lead the team delivering these cutting-edge services, ensuring patients benefit from highly advanced imaging technology, including WA’s first Siemens Biograph Trinion PET-CT and Symbia Pro.specta X3 SPECT/CT systems.
Julie Crouch, Icon Group Director of Molecular Oncology, congratulated Nick on his appointment, highlighting the impact of his leadership.
Nick’s extensive background in nuclear medicine and his collaborative leadership style makes him an outstanding addition to Icon. We’re excited to see the passion and expertise he brings to shaping our first theranostics and imaging centre, and I know he will build a strong, supportive culture for both our doctors and patients.
We warmly welcome Nick to the Icon team as he leads the delivery of cutting-edge theranostics services, providing patients across Western Australia and beyond with access to world-class personalised cancer care, closer to home.
Please join us in congratulating Nick on this exciting new role!
Discover our comprehensive collection of content designed to inform, support, and guide you through every aspect of cancer care. From the latest news and updates to personal patient experiences and educational resources, these materials provide valuable insights to help you better understand cancer, treatment options, and the journey ahead.